Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 1.0 | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.42 | 1.23 |
NAV | ₹10.02 | ₹30.45 |
Fund Started | 17 Jan 2022 | 05 Feb 2020 |
Fund Size | ₹413.83 Cr | ₹195.06 Cr |
Exit Load | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 12 months. | Exit load of 1% if redeemed within 12 months. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -20.92% | 0.40% |
3 Year | 1.90% | 20.57% |
5 Year | - | 24.50% |
1 Year
3 Year
5 Year
Equity | 99.00% | 0.00% |
Cash | 0.66% | 100.00% |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Bharat Electronics Ltd. | 8.09% |
Solar Industries India Ltd. | 6.16% |
Astrazeneca Pharma India Ltd. | 5.79% |
Coforge Ltd. | 5.75% |
Abbott India Ltd. | 5.04% |
Central Depository Services (India) Ltd. | 4.80% |
Muthoot Finance Ltd. | 4.46% |
Coromandel International Ltd. | 4.01% |
LT Foods Ltd. | 3.85% |
Gillette India Ltd. | 3.82% |
Name | Umeshkumar Mehta | Dharmesh Kakkad |
Start Date | 03 Apr 2024 | 23 Feb 2021 |
Name
Start Date
Description | The scheme seeks to generate long-term capital growth from an actively managed portfolio of Indian & foreign equity instruments across market capitalisation. | The Scheme seeks to generate returns by predominantly investing in one or more mutual fund schemes /ETFs (managed by ICICI Prudential Mutual Fund or any other Mutual Fund(s)) which invest in equity and equity related securities. |
Launch Date | 17 Jan 2022 | 05 Feb 2020 |
Description
Launch Date